Nalaganje...

Allogeneic major histocompatibility complex‐mismatched equine bone marrow‐derived mesenchymal stem cells are targeted for death by cytotoxic anti‐major histocompatibility complex antibodies

BACKGROUND: Allogeneic mesenchymal stem cells (MSCs) are a promising cell source for treating musculoskeletal injuries in horses. Controversy exists, however, over whether major histocompatibility complex (MHC)‐mismatched MSCs are recognised by the recipient immune system and targeted for death by a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Equine Vet J
Main Authors: Berglund, A.K., Schnabel, L.V.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2016
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5425313/
https://ncbi.nlm.nih.gov/pubmed/27862236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/evj.12647
Oznake: Označite
Brez oznak, prvi označite!